These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6872170

  • 1. Clinical pharmacology of propafenone.
    Connolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA.
    Circulation; 1983 Sep; 68(3):589-96. PubMed ID: 6872170
    [Abstract] [Full Text] [Related]

  • 2. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M, Salerno D, Granrud G.
    Am J Cardiol; 1984 Nov 14; 54(9):45D-50D. PubMed ID: 6388303
    [Abstract] [Full Text] [Related]

  • 3. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC, Sorenson PB, Wood DL, Sugrue DD, Osborn MJ, Gersh BJ, Holmes DR.
    Mayo Clin Proc; 1986 Feb 14; 61(2):98-103. PubMed ID: 3945115
    [Abstract] [Full Text] [Related]

  • 4. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L, Myburgh DP, Schamroth CL, Scholtz ME, Pincus DR, Kawalsky DL.
    Chest; 1985 Apr 14; 87(4):448-51. PubMed ID: 3884286
    [Abstract] [Full Text] [Related]

  • 5. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F, Bracchetti D, Palmieri M, Cantelli I, Bertaccini P, Ambrosioni E.
    Am Heart J; 1985 Apr 14; 109(4):833-40. PubMed ID: 3885700
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
    Salerno DM, Granrud G, Sharkey P, Asinger R, Hodges M.
    Am J Cardiol; 1984 Jan 01; 53(1):77-83. PubMed ID: 6362387
    [Abstract] [Full Text] [Related]

  • 7. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 8. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN, Kaplinsky E, Kirsten E, Guerrero J.
    Am Heart J; 1988 Dec 14; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [Abstract] [Full Text] [Related]

  • 9. Propafenone disposition kinetics in cardiac arrhythmia.
    Connolly S, Lebsack C, Winkle RA, Harrison DC, Kates RE.
    Clin Pharmacol Ther; 1984 Aug 14; 36(2):163-8. PubMed ID: 6744775
    [Abstract] [Full Text] [Related]

  • 10. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H.
    Z Kardiol; 1988 Jul 14; 77(7):464-9. PubMed ID: 2463720
    [Abstract] [Full Text] [Related]

  • 11. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P.
    G Ital Cardiol; 1986 Apr 14; 16(4):328-32. PubMed ID: 2427383
    [Abstract] [Full Text] [Related]

  • 12. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS, Rieder L.
    Z Gerontol; 1985 Apr 14; 18(6):343-52. PubMed ID: 2420079
    [Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.
    Winkle RA, Peters F, Kates RE, Tucker C, Harrison DC.
    Circulation; 1981 Aug 14; 64(2):290-6. PubMed ID: 6788400
    [Abstract] [Full Text] [Related]

  • 14. Propafenone: a new agent for ventricular arrhythmia.
    Podrid PJ, Lown B.
    J Am Coll Cardiol; 1984 Jul 14; 4(1):117-25. PubMed ID: 6376591
    [Abstract] [Full Text] [Related]

  • 15. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N, Terry L, Murphy ML, Thompson CH, Doherty JE, Sakhaii M, Dinh H.
    Am Heart J; 1984 Aug 14; 108(2):285-9. PubMed ID: 6380253
    [Abstract] [Full Text] [Related]

  • 16. Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response relations.
    Siddoway LA, Roden DM, Woosley RL.
    Am J Cardiol; 1984 Nov 14; 54(9):9D-12D. PubMed ID: 6496371
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G.
    Eur Heart J; 1985 Feb 14; 6(2):123-9. PubMed ID: 3891347
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R, Skrabucha B, Kunicki PK, Kowalik I, Skorykow-Sapińska A, Sitkiewicz D, Sadowski Z.
    Pol Arch Med Wewn; 1998 Apr 14; 99(4):323-30. PubMed ID: 9760820
    [Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.
    Frabetti L, Marchesini B, Capucci A, Cavallini C, Gubelli S, Ambrosioni E, Magnani B.
    Eur J Clin Pharmacol; 1986 Apr 14; 30(6):665-71. PubMed ID: 2429844
    [Abstract] [Full Text] [Related]

  • 20. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW, Rotem CE, Boroomand-Rashti K, Bar-Shlomo B.
    Can Med Assoc J; 1984 Sep 15; 131(6):601-3. PubMed ID: 6478345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.